HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Linda E Wellik Selected Research
Linda E Wellik Research Topics
Disease
6
Neoplasms (Cancer)
10/2023 - 01/2012
3
Lymphoma (Lymphomas)
01/2021 - 01/2012
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 03/2012
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017 - 11/2012
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 05/2009
1
Urinary Calculi (Urinary Calculus)
01/2022
1
Carcinogenesis
12/2021
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2021
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2020
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2018
1
Burkitt Lymphoma (Burkitt's Lymphoma)
03/2012
1
Disease Progression
03/2012
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2012
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2012
1
Sezary Syndrome (Sezary Erythroderma)
01/2012
1
Primary Myelofibrosis (Myelosclerosis)
01/2005
1
Hematologic Neoplasms (Hematological Malignancy)
01/2005
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
01/2021 - 11/2018
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2012 - 01/2005
2
Sirolimus (Rapamycin)
FDA Link
03/2012 - 01/2012
1
Protein Isoforms (Isoforms)
IBA
10/2023
1
Long Noncoding RNA
IBA
12/2021
1
Glutathione (Reduced Glutathione)
IBA
01/2020
1
Immunoglobulin M (IgM)
IBA
01/2020
1
Tyrosine (L-Tyrosine)
FDA Link
11/2018
1
ibrutinib
IBA
01/2017
1
Ligands
IBA
01/2017
1
6- (4- (1H- 1,2,4- triazol- 3- yl)phenyl)- 1- (2- (tetrahydro- 2H- pyran- 4- yl)ethyl)- 1H- imidazo(4,5- b)pyrazin- 2(3H)- one
IBA
04/2015
1
Phosphotransferases (Kinase)
IBA
04/2015
1
Eukaryotic Initiation Factor-4E
IBA
04/2015
1
Eukaryotic Initiation Factor-4F (EIF4F)
IBA
04/2015
1
Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)
IBA
04/2015
1
Cyclin D3
IBA
04/2015
1
epratuzumab
IBA
11/2012
1
Rituximab (Mabthera)
FDA Link
11/2012
1
Sorafenib (BAY 43-9006)
FDA Link
03/2012
1
OSI 027
IBA
01/2012
1
TOR Serine-Threonine Kinases
IBA
01/2012
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2012
1
Mechanistic Target of Rapamycin Complex 2
IBA
01/2012
Therapy/Procedure
3
Therapeutics
11/2018 - 11/2012
1
Nephrectomy
01/2022